In the evolving landscape of investing, gaining access to private companies like OpenAI, SpaceX, and Anthropic has typically demanded significant capital or connections. However, Injective is breaking down these barriers by launching on-chain pre-IPO stocks for these high-profile firms, making them accessible to a broader audience.
Injective, a layer-1 blockchain tailored for decentralized finance, is democratizing investment opportunities with the introduction of tokenized stocks. This initiative follows their previous introduction in October 2025 of pre-IPO perpetual futures. These synthetic contracts allowed investors to speculate on the future valuation of private companies without holding actual shares, generating $1 billion in trading volume in just the first month.
In August 2025, Injective established crucial groundwork by partnering with Republic, an investment platform known for facilitating retail investors' access to private equity markets. This collaboration provided a seamless connection between traditional private markets and Injective's innovative on-chain infrastructure.
Why is Injective focusing on OpenAI, SpaceX, and Anthropic? Each of these companies represents a critical part of the generative AI landscape. OpenAI, known for its development of ChatGPT, is at the forefront of artificial intelligence. Anthropic, a competitor backed by tech giants Amazon and Google, is also a significant player. The AI sector alone attracted over $100 billion in investment in 2024, illustrating the rising interest among retail investors.
Historically, private equity markets have been exclusive realms, accessible mainly to accredited investors and venture capitalists. The global private equity sector is valued at more than $13 trillion, highlighting the immense potential for retail investors now that tokenized stocks are available.
It's essential to understand that tokenized stocks do not operate the same way as shares in a conventional brokerage account. The legal protections, settlement processes, and regulatory frameworks governing these tokens vary. For instance, owning a traditional share of SpaceX comes with certain rights, such as voting and dividend claims, protected by extensive securities law. However, the validity of on-chain representations of those shares can differ based on their tokenization and the investor's location.
The U.S. Securities and Exchange Commission has historically looked upon products that blur the line between cryptocurrency and securities with caution. For Injective's native token, INJ, the upcoming launch of these tokenized stocks could act as a pivotal catalyst. Community sentiment appears positive, with speculation that INJ could eventually reach valuations similar to well-established layer-1 tokens such as SOL or XRP.
Retail investors are urged to consider the implications of this innovative approach to investing in private equity, ensuring they have a clear understanding of the risks and rewards involved.